SCHEMBL7129226

SCHEMBL7129226

CC(C)(C)OC(=O)Nc1cccc(-c2csc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.56
KMT2A Q03164 8/20 0.56
MAPT P10636 8/20 0.56
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 1/20 0.56
HDAC3 O15379 4/20 0.55
HDAC1 Q13547 3/20 0.55
HDAC2 Q92769 3/20 0.55
HDAC10 Q969S8 3/20 0.55
HDAC8 Q9BY41 2/20 0.55
HTT P42858 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
BAZ1A Q9NRL2 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
LMNA P02545 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7119667 0.91 RAB9A (0.53) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7128853 0.89 MAPT (0.62) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7123649 0.87 MEN1 (0.62) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7130345 0.85 MEN1 (0.73) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7128172 0.84 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7128794 0.82 MEN1 (0.69) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7125926 0.82 MEN1 (0.64) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7129830 0.81 PPARG (0.59) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7127621 0.80 ABL1 (0.63) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL7128929 0.80 RAB9A (0.67) MEN1KMT2AMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MEN1 4865/4885KMT2A 3291/4885MAPT 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.